Endocrinoloxía e nutrición

1996

1. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli

   Journal of Clinical Endocrinology and Metabolism, Vol. 81, Núm. 3, pp. 909-913

2. Correlation between the effects of bombesin antagonists on cell proliferation and intracellular calcium concentration in Swiss 3T3 and HT-29 cell lines

   Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, Núm. 4, pp. 1406-1411

3. Differentiated carcinoma of the thyroid gland in an area of endemic goiter. Clinical study and prognostic correlation

   Anales de medicina interna (Madrid, Spain : 1984), Vol. 13, Núm. 11, pp. 537-540

4. Estudio del zinc sérico en la degeneración macular asociada a la edad

   Archivos de la Sociedad Española de Oftalmologia, Vol. 71, Núm. 6, pp. 619-622

5. Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome

   Clinical Endocrinology, Vol. 45, Núm. 4, pp. 385-390

6. Growth hormone secretion induced by growth hormone releasing hormone (GHRH), pyridostigmine and ghrh plus growth hormone releasing peptide-6 after acute blockade of lipolysis with acipimox in obese individuals

   Endocrinology and Metabolism, Supplement, Vol. 3, Núm. SUPPL. A, pp. 143

7. Hipotiroidismo subclinico: Concepto, etiologia, repercusiones y tratamiento

   Endocrinologia, Vol. 43, Núm. 5, pp. 152-155

8. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression

   Journal of Clinical Endocrinology and Metabolism, Vol. 81, Núm. 3, pp. 914-918

9. La hipertransaminasemia transitoria aislada como complicación de hipertrigliceridemia

   Cadernos de atención primaria, Vol. 3, Núm. 3, pp. 144

10. MRI of mediastinal parathyroid cystic adenoma causing hyperparathyroidism

    Journal of Computer Assisted Tomography, Vol. 20, Núm. 1, pp. 166-168

11. Partial characterization of a putative new growth factor present in pathological human vitreous

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 234, Núm. 3, pp. 155-163

12. Pituitary enlargement due to primary hypothyroidism: Growth hormone response to GHRH, GHRP-6 and GHRH plus GHRP-6

    Journal of Pediatric Endocrinology and Metabolism, Vol. 9, Núm. 5, pp. 549-553

13. Role of the new growth hormone-releasing secretagogues in the diagnosis of some hypothalamopituitary pathologies

    Metabolism: Clinical and Experimental, Vol. 45, Núm. SUPPL.1, pp. 123-126

14. Serum immunoreactive-leptin levels are increased in patients with Cushing's syndrome

    Hormone and Metabolic Research, Vol. 28, Núm. 12, pp. 711-713

15. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man

    Clinical Endocrinology, Vol. 45, Núm. 5, pp. 543-551

16. Utility of magnetic resonance in the etiologic diagnosis of hypopituitarism

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 13, Núm. 12, pp. 584-588

17. Varón con hepatoesplenomegalia, pancitopenia y dolor en muslo izquierdo

    Revista Clinica Espanola, Vol. 196, Núm. 11, pp. 785-786